[Anti-proliferative effects of biochemical defense modifier antineoplaston in colorectal carcinoma].
Ogata
Yutaka
Y
Department of Surgery, Kurume University School of Medicine.
Matono
Keiko
K
Shirouzu
Kazuo
K
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D044482:Benzeneacetamides / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects / Q000235:genetics; D018797:Cell Cycle Proteins / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005973:Glutamine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary; D051379:Mice; D008819:Mice, Nude; D010648:Phenylacetates / Q000494:pharmacology*; D010881:Piperidones / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D044482:Benzeneacetamides; D018797:Cell Cycle Proteins; D004338:Drug Combinations; D010648:Phenylacetates; D010881:Piperidones; D005973:Glutamine; C092038:antineoplaston AS 2-1; C052091:antineoplaston A10